Figure 3
Figure 3. Changes in α-actinin phosphorylation and its interaction with αIIbβ3 in platelets from patients with Glanzmann thrombasthenia or P2Y12 deficiency. (A) Platelet lysates from patients with Glanzmann thrombasthenia or patients with P2Y12 deficiency were subjected to SDS–polyacrylamide gel electrophoresis and immunoblotted with anti-αIIbβ3 antibody or anti–α-actinin antibody. (B) Washed platelets were stimulated with PAR1-AP (25μM) or PAR4-AP (150μM) for the time indicated. Tyrosine-phosphorylated proteins were immunoprecipitated then immunoblotted with anti–α-actinin antibody. (C) Washed normal platelets were stimulated with PAR4-AP (150μM) for the time indicated after incubation with AR-C69931MX (1μM) for 2 minutes. αIIbβ3 was immunoprecipitated then immunoblotted with anti–α-actinin antibody. (D) Washed normal platelets were stimulated with PAR4-AP (150μM) for the time indicated after incubation with AR-C69931MX (1μM) for 2 minutes. FITC–PAC-1 was added to the activated platelets after stimulation and incubated for 30 seconds to obtain the PAC-1 binding velocity at the time indicated. Error bars represent SEMs of 3 experiments.

Changes in α-actinin phosphorylation and its interaction with αIIbβ3 in platelets from patients with Glanzmann thrombasthenia or P2Y12 deficiency. (A) Platelet lysates from patients with Glanzmann thrombasthenia or patients with P2Y12 deficiency were subjected to SDS–polyacrylamide gel electrophoresis and immunoblotted with anti-αIIbβ3 antibody or anti–α-actinin antibody. (B) Washed platelets were stimulated with PAR1-AP (25μM) or PAR4-AP (150μM) for the time indicated. Tyrosine-phosphorylated proteins were immunoprecipitated then immunoblotted with anti–α-actinin antibody. (C) Washed normal platelets were stimulated with PAR4-AP (150μM) for the time indicated after incubation with AR-C69931MX (1μM) for 2 minutes. αIIbβ3 was immunoprecipitated then immunoblotted with anti–α-actinin antibody. (D) Washed normal platelets were stimulated with PAR4-AP (150μM) for the time indicated after incubation with AR-C69931MX (1μM) for 2 minutes. FITC–PAC-1 was added to the activated platelets after stimulation and incubated for 30 seconds to obtain the PAC-1 binding velocity at the time indicated. Error bars represent SEMs of 3 experiments.

Close Modal

or Create an Account

Close Modal
Close Modal